Stella-Jones Inc. (TSE:SJ – Get Free Report) insider Marco Albanesi bought 206 shares of Stella-Jones stock in a transaction on Tuesday, May 12th. The shares were purchased at an average cost of C$73.00 per share, with a total value of C$15,038.00. Following the completion of the purchase, the insider directly owned 826 shares in the company, valued at C$60,298. This trade represents a 33.23% increase in their ownership of the stock.
Stella-Jones Price Performance
Shares of TSE:SJ opened at C$73.56 on Friday. The firm’s 50 day moving average is C$87.69 and its two-hundred day moving average is C$88.03. The firm has a market capitalization of C$4.01 billion, a P/E ratio of 13.33, a PEG ratio of 2.40 and a beta of -0.15. The company has a current ratio of 4.96, a quick ratio of 1.20 and a debt-to-equity ratio of 80.71. Stella-Jones Inc. has a 52 week low of C$69.94 and a 52 week high of C$101.31.
Stella-Jones (TSE:SJ – Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The company reported C$1.12 earnings per share (EPS) for the quarter. Stella-Jones had a return on equity of 14.85% and a net margin of 8.66%.The business had revenue of C$791.00 million during the quarter. Analysts anticipate that Stella-Jones Inc. will post 6.4457565 earnings per share for the current year.
Analysts Set New Price Targets
Get Our Latest Analysis on Stella-Jones
Stella-Jones Company Profile
Stella-Jones Inc produces and sells lumber and wood products. The company operates in two segments: Pressure-treated wood, which includes utility poles, railway ties, residential lumber, and industrial products; and Logs & Lumber segment comprises of the sales of logs harvested in the course of the company’s procurement process that is determined to be unsuitable for use as utility poles, it also includes the sale of excess lumber to local home-building markets. The vast majority of its revenue comes from the Pressure-treated wood segment.
Featured Stories
- Five stocks we like better than Stella-Jones
- 2 Ways to Play the Big Pharma Patent Cliff
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
- Cisco’s Vertical Rally May Still Be in the Early Innings
Receive News & Ratings for Stella-Jones Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stella-Jones and related companies with MarketBeat.com's FREE daily email newsletter.
